Synergetics USA, Inc., a leading provider in the medical device industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1991, the company has established itself as a pioneer in innovative surgical solutions, particularly in the fields of ophthalmology and neurosurgery. Synergetics is renowned for its advanced surgical instruments and technologies, which are designed to enhance precision and efficiency in complex procedures. Their commitment to quality and innovation has positioned them as a trusted partner for healthcare professionals worldwide. With a focus on improving patient outcomes, Synergetics continues to achieve notable milestones, solidifying its reputation as a key player in the medical device sector.
How does Synergetics USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Synergetics USA, Inc.'s score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Synergetics USA, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Bausch Health Companies Inc., which means that any climate commitments or emissions data would be inherited from this parent organisation. As part of its corporate family, Synergetics USA, Inc. aligns with the climate initiatives and targets set by Bausch Health Companies Inc. However, specific reduction targets or achievements for Synergetics USA, Inc. are not detailed in the available information. The company does not appear to have its own distinct climate pledge or specific reduction initiatives listed. For a comprehensive understanding of Synergetics USA, Inc.'s climate commitments, stakeholders may need to refer to the broader sustainability efforts and emissions data reported by Bausch Health Companies Inc., which may include industry-standard climate terminology and reduction strategies.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
Synergetics USA, Inc.'s Scope 3 emissions, which increased by 41% last year and increased by approximately 41% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 21% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Synergetics USA, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.